The 5-year survival rate has been estimated at 33% and the 10-year survival rate at 12%.
Progressive muscular atrophy
Progressive bulbar palsy
Lipodystrophy
Multifocal motor neuropathy
Cerebral atrophy
Osteodystrophy
Facial onset sensory and motor neuropathy
Progressive inflammatory neuropathy